NCT07544238 Prospective Study of Minimally Invasive (Laparoscopic and Robotic) Hernia Repair (Incisional and Primary, Midline and Lateral, Not Inguinal)
| NCT ID | NCT07544238 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz |
| Condition | Ventral Hernia Midline |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2036-04-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-04-14 with a primary completion date of 2036-04-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The participating researchers register all adult patients (who have given informed written consent) scheduled for elective repair of an abdominal wall hernia (NOT inguinal hernias) via minimally invasive operation technique (i.e.: laparoscopy or robotic repair) and perform a follow up of 5 years to analyze clinical outcome parameters. These parameters include recurrence of the hernia, intra- and postoperative complications, quality of live, esthetic outcome and pain. The patients will be reviewed in person by the participating researchers at 2-3 moths, 1 year, 3 years and 5 years after surgery. A computed tomography will be performed at 1 year after surgery and in case of suspicion of complications, for example hernia recurrence. The treatment and follow-up of the participating patients does not differ from the standard treatment protocol (and the not participating patients).
Eligibility Criteria
Inclusion Criteria: * Indication for elective minimally invasive ventral hernia repair due to criteria of the participating surgeons Exclusion Criteria: * Patient rejects participation or giving written informed consent * Positive pregnancy test (Beta HCG in serum) * Patients who do not meet criteria for minimally invasive surgery due to the criteria of the including surgeon or anesthesiologist (Loss of domain, giant abdominal wall herniae, very small (W1) isolated midline hernia, severe pulmonary or cardiac pathologies)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07544238 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ventral Hernia Midline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07544238 currently recruiting?
Yes, NCT07544238 is actively recruiting participants. Contact the research team at marius.kaser@quironsalud.es for enrollment information.
Where is the NCT07544238 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT07544238 clinical trial?
NCT07544238 is sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. The trial plans to enroll 400 participants.